Authors: Keltner, JL Thirkill, CE Yip, PT

Citation: Jl. Keltner et al., Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: Eleven new cases and a review of 51 previously published cases, J NEURO-OPH, 21(3), 2001, pp. 173-187

Authors: Keltner, JL Johnson, CA Quigg, JM Cello, KE Kass, MA Gordon, MO

Citation: Jl. Keltner et al., Confirmation of visual field abnormalities in the ocular hypertension treatment study, ARCH OPHTH, 118(9), 2000, pp. 1187-1194

Authors: Keltner, JL Thirkill, CE

Citation: Jl. Keltner et Ce. Thirkill, The 22-kDa antigen in optic nerve and retinal diseases, J NEURO-OPH, 19(2), 1999, pp. 71-83

Authors: Keltner, JL

Citation: Jl. Keltner, Graves ophthalmopathy - In reply, ARCH OPHTH, 117(5), 1999, pp. 700-700

Authors: Keltner, JL Johnson, CA Spurr, JO Beck, RW

Citation: Jl. Keltner et al., Comparison of central and peripheral visual field properties in the optic neuritis treatment trial, AM J OPHTH, 128(5), 1999, pp. 543-553

Authors: Keltner, JL

Citation: Jl. Keltner, Cancer-associated retinopathy vs recoverin-associated retinopathy (vol 126, pg 296, 1998), AM J OPHTH, 126(6), 1998, pp. 866-866